As a direct miR-375 target, SHOX2 promotes the epithelial-to-mesenchymal transition (EMT) of breast cancer cells through the up-regulation of transforming growth factor β (TNF-β) signaling [8]. Here, SHOX2 is linked to breast carcinoma.